PT  - JOURNAL ARTICLE
AU  - Bulut, Tevfik
TI  - New Epidemiological Model Suggestions Revealing Size of Epidemics Based on the COVID-19 Pandemic Example: Wavelength Models
AID  - 10.1101/2020.04.07.20056432
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.07.20056432
4099  - http://medrxiv.org/content/early/2020/04/16/2020.04.07.20056432.short
4100  - http://medrxiv.org/content/early/2020/04/16/2020.04.07.20056432.full
AB  - The main purpose of the study is to introduce the wavelength models developed to measure the size of outbreaks based on the COVID-19 example. In this way, the wavelengths of the outbreaks can be calculated, ensuring that the outbreaks are valid, reliable and easy to follow at the national and international level. Wavelength models consist of approved case, death, recovered case and net wavelength models. Thus, the size of the outbreak can be measured both individually and as a whole. COVID-19 cases of 181 countries were used to demonstrate the application of the models. The prominent findings in the applied wavelength models are as follows: the countries with the highest case wavelength are USA, Italy, Spain and Germany, respectively. However, Italy ranks first in the death wavelength, followed by Spain, the USA and France. On the other hand, China has taken the first place in the recovered case wavelength. This country was followed by Spain and Germany and Italy, respectively. Based on all these wavelength models mentioned, net wavelength lengths are calculated. According to the findings of net wavelengths obtained, Canada ranked first, followed by United Kingdom, USA and Italy, respectively.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding support was received within the scope of the study.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll of the data presented in this study is available on The Humanitarian Data Exchange (HDX) (https://data.humdata.org/dataset/novel-coronavirus-2019-ncov-cases). https://data.humdata.org/dataset/novel-coronavirus-2019-ncov-cases